Zimmer Biomet Holdings, Inc. (ZBH) Total Return:-1.84%(TTM)
Over the latest trailing 12-month period, Zimmer Biomet Holdings, Inc. (ZBH)'s total return cagr is -1.84%. The comparable SPY value is +26.75%. Year-to-date total return is -1.91%. Total return includes price appreciation and reinvested dividends.
Growth of $10,000 in ZBH
$34,407
(3.4x return)
Invested on Jul 25, 2001
Growth of $10,000 in SPY (S&P 500)
$97,104
(9.7x return)
Invested on Jul 25, 2001
Hypothetical Growth of $10,000
This chart illustrates the cumulative performance of a hypothetical $10,000 investment. It assumes that all dividends paid by both the stock and SPY are reinvested in additional shares on the payment date, showing the true long-term compounding impact of distributions.
Recent Performance Indicators
YTD Total Return
-1.9%
1-Year Total Return
-1.8%
Current Dividend Yield
1.09%
Price CAGR vs. Total Return CAGR
Compound Annual Growth Rate (CAGR) is shown below. The difference between price CAGR and total return CAGR is the compound contribution of dividends reinvested.
| Holding Period | Price CAGR | Total Return CAGR | Dividend Addition |
|---|---|---|---|
| 1 Year | (2.9%) | (1.8%) | +1.0% |
| 3 Years | (15.1%) | (14.4%) | +0.8% |
| 5 Years | (10.6%) | (9.8%) | +0.8% |
| 10 Years | (2.5%) | (1.7%) | +0.8% |
| 15 Years | +2.6% | +3.4% | +0.8% |
| 20 Years | +1.6% | +2.2% | +0.6% |
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ivan Tornos